» Articles » PMID: 11642011

Subacute Toxicity of Chitosan Oligosaccharide in Sprague-Dawley Rats

Overview
Specialty Pharmacology
Date 2001 Oct 20
PMID 11642011
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

A subacute oral toxicity study of chitosan oligosaccharide was performed in Sprague-Dawley rats of both sexes. Each 36 male and female rats were administered by gavage with 500, 1,000 and 2,000 mg/kg/day for 4 weeks (7 days/week), respectively. Examinations regarding clinical signs, body weights, hematological and biochemical parameters, and histopathological examinations were carried out. There were no significant differences in behavior or external appearance, body weight and food consumption between control and treated rats. In addition, no significant differences in urinalysis, hematology, blood biochemistry, relative organ weights and histopathological findings were found in both control and treated rats. In conclusion, it was suggested that subacute toxicity of chitosan oligosaccharide was low and the no-observed adverse effect level was considered to be over 2,000 mg/kg in rats.

Citing Articles

Enhancing immune response, antioxidant capacity, and gut health in growing beagles through a chitooligosaccharide diet.

Cheng G, Hu T, Zeng Y, Yan L, Liu Y, Wang Y Front Vet Sci. 2024; 10:1283248.

PMID: 38274661 PMC: 10808298. DOI: 10.3389/fvets.2023.1283248.


Antidiabetic Properties of Chitosan and Its Derivatives.

Tzeng H, Liu S, Chiang M Mar Drugs. 2022; 20(12).

PMID: 36547931 PMC: 9782916. DOI: 10.3390/md20120784.


Chitosan Oligosaccharide Supplementation Affects Immunity Markers in Ewes and Lambs during Gestation and Lactation.

Jahan M, Wilson C, McGrath S, Francis N, Wynn P, Du Y Animals (Basel). 2022; 12(19).

PMID: 36230349 PMC: 9558557. DOI: 10.3390/ani12192609.


Chitosan and Chitooligosaccharide: The Promising Non-Plant-Derived Prebiotics with Multiple Biological Activities.

Guan Z, Feng Q Int J Mol Sci. 2022; 23(12).

PMID: 35743209 PMC: 9223384. DOI: 10.3390/ijms23126761.


Structural features, interaction with the gut microbiota and anti-tumor activity of oligosaccharides.

Wu Y, Chen Y, Lu Y, Hao H, Liu J, Huang R RSC Adv. 2022; 10(28):16339-16348.

PMID: 35498870 PMC: 9053055. DOI: 10.1039/d0ra00344a.